September 2019 Archive UM Ventures News Partner News Technical.ly Baltimore: UMB grants licensing option for anticancer drug that uses AnthraxThursday, September 19, 2019 University of Maryland, Baltimore Grants Spherix Exclusive Option to License Anthrax Based Ovarian Cancer Drug PrAg-PASTuesday, September 17, 2019